Clinical Trial Update: Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of vortioxetine for generalized anxiety disorder in adults; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Vortioxetine (Lu AA21004) (vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-03-03